Myelodysplastic syndrome with concomitant del(5q) and JAK2 V617F mutation transformed to acute myeloid leukemia with an additional chromosomal abnormality after a long-term treatment with lenalidomide.
about
Myelodysplastic syndrome with concomitant del(5q) and JAK2 V617F mutation transformed to acute myeloid leukemia with an additional chromosomal abnormality after a long-term treatment with lenalidomide.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Myelodysplastic syndrome with concomitant del
@nl
Myelodysplastic syndrome with ...... m treatment with lenalidomide.
@en
type
label
Myelodysplastic syndrome with concomitant del
@nl
Myelodysplastic syndrome with ...... m treatment with lenalidomide.
@en
prefLabel
Myelodysplastic syndrome with concomitant del
@nl
Myelodysplastic syndrome with ...... m treatment with lenalidomide.
@en
P2093
P2860
P1433
P1476
Myelodysplastic syndrome with ...... m treatment with lenalidomide.
@en
P2093
Masaharu Nohgawa
Satoko Oka
P2860
P304
P356
10.1080/10428194.2017.1295146
P577
2017-02-28T00:00:00Z